These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 34013797

  • 1. Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging.
    Tuncel H, Boellaard R, Coomans EM, de Vries EF, Glaudemans AW, Feltes PK, García DV, Verfaillie SC, Wolters EE, Sweeney SP, Ryan JM, Ivarsson M, Lynch BA, Schober P, Scheltens P, Schuit RC, Windhorst AD, De Deyn PP, van Berckel BN, Golla SS.
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1338-1350. PubMed ID: 34013797
    [Abstract] [Full Text] [Related]

  • 2. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.
    Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE.
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
    [Abstract] [Full Text] [Related]

  • 3. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.
    Koole M, van Aalst J, Devrome M, Mertens N, Serdons K, Lacroix B, Mercier J, Sciberras D, Maguire P, Van Laere K.
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895
    [Abstract] [Full Text] [Related]

  • 4. In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease.
    Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S.
    Neuroimage; 2021 Oct 01; 239():118302. PubMed ID: 34174391
    [Abstract] [Full Text] [Related]

  • 5. Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice.
    Bertoglio D, Verhaeghe J, Miranda A, Kertesz I, Cybulska K, Korat Š, Wyffels L, Stroobants S, Mrzljak L, Dominguez C, Liu L, Skinbjerg M, Munoz-Sanjuan I, Staelens S.
    J Cereb Blood Flow Metab; 2020 Jun 01; 40(6):1351-1362. PubMed ID: 31307287
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y.
    J Nucl Med; 2016 May 01; 57(5):777-84. PubMed ID: 26848175
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain.
    Varnäs K, Stepanov V, Halldin C.
    Synapse; 2020 Oct 01; 74(10):e22157. PubMed ID: 32259300
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, Alagille D, Sandiego CM, Papin C, Marek K, Seibyl JP, Tamagnan GD, Barret O.
    Mol Imaging Biol; 2019 Jun 01; 21(3):509-518. PubMed ID: 30084043
    [Abstract] [Full Text] [Related]

  • 14. First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.
    Naganawa M, Li S, Nabulsi N, Henry S, Zheng MQ, Pracitto R, Cai Z, Gao H, Kapinos M, Labaree D, Matuskey D, Huang Y, Carson RE.
    J Nucl Med; 2021 Apr 01; 62(4):561-567. PubMed ID: 32859701
    [Abstract] [Full Text] [Related]

  • 15. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study.
    Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE.
    Epilepsia; 2020 Oct 01; 61(10):2183-2193. PubMed ID: 32944949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging.
    Sadasivam P, Fang XT, Toyonaga T, Lee S, Xu Y, Zheng MQ, Spurrier J, Huang Y, Strittmatter SM, Carson RE, Cai Z.
    Mol Imaging Biol; 2021 Jun 01; 23(3):372-381. PubMed ID: 33258040
    [Abstract] [Full Text] [Related]

  • 18. Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies.
    Tuncel H, Visser D, Yaqub M, Timmers T, Wolters EE, Ossenkoppele R, van der Flier WM, van Berckel BNM, Boellaard R, Golla SSV.
    Mol Imaging Biol; 2021 Aug 01; 23(4):604-613. PubMed ID: 33496930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.